ME/CFS research at Haukeland University Hospital - Norway
Myalgic encephalomyelitis (ME) – also known as chronic fatigue syndrome (CFS) is a complex condition with no known cause which affects some 0.2 per cent of Norwegians.
The main symptom is a long-lasting and at times debilitating exhaustion.
The Kavli Trust has been supporting work by cancer specialists Olav Mella and Øystein Flude at Haukeland University Hospital in Bergen since 2011.
Their hypothesis is that ME could be an autoimmune condition – in other words, the body has come under attack from its own immune system.
More about this project
The Kavli Trust renews its support for ME research at Haukeland University Hospital
September 14, 2018
The Kavli Trust in Norway is continuing its long cooperation with the research group for ME/CFS at Haukeland University Hospital, supporting further biomedical research with NOK 4.72 million in 2018 and 2019.
Continued backing for ME work
June 26, 2017
The Kavli Trust is extending its collaboration over biomedical research on chronic fatigue syndrome or myalgic encephalopathy (ME) at Haukeland University Hospital in Bergen.
New study on pathological mechanisms in ME from Bergen research group
December 22, 2016
A new study, partly funded by the Kavli Trust, suggests that the PDH enzyme is inhibited in ME/CFS patients, which may explain both energy shortage and increased lactate production in these patients. These findings have now been published in the Journal of Clinical Investigation Insight.
Millions of kroner donated for ME research
September 21, 2015
Further substantial grants are being made by the Kavli Trust to support promising research on chronic fatigue syndrome or myalgic encephalomyelitis (ME).
Tackling a medical mystery
April 10, 2015
What exactly is myalgic encephalopathy (ME), also known as chronic fatigue syndrome (CFS), and how can it be treated? Answers to these questions are being sought by cancer specialists at Norway’s Haukeland University Hospital with support from the Kavli Trust.
Hope for CFS/ME patients
October 19, 2011